We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Loss of Tumor Suppressor Gene Spurs Growth of Some Malignant Melanomas

By LabMedica International staff writers
Posted on 17 Nov 2015
Print article
Image: Metastatic melanoma tumors. The micrograph on the left shows low or absent expression of RASA2, which is linked to reduced survival of about 35% of patients. The sample on the right exhibits high RASA2 expression and increased survival (Photo courtesy of the Weizmann Institute of Science).
Image: Metastatic melanoma tumors. The micrograph on the left shows low or absent expression of RASA2, which is linked to reduced survival of about 35% of patients. The sample on the right exhibits high RASA2 expression and increased survival (Photo courtesy of the Weizmann Institute of Science).
Cancer researchers have identified a tumor suppressor gene that when damaged or lost acts to spur growth and spread of a subset of human malignant melanomas.

Investigators at the Weizmann Institute of Science (Rehovot, Israel) reviewed data that had been accumulated during the genome and exome analysis of 501melanoma specimens. They reported in the October 26, 2015, online edition of the journal Nature Genetics that the RASA2 (RAS p21 protein activator 2) gene, which encodes a RasGAP (Ras GTPase activating protein), functioned as a tumor-suppressor gene that was mutated in 5% of melanomas.

The protein encoded by RASA2 is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its cancer-promoting counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with cancer formation.

Recurrent loss-of-function mutations in RASA2 were found to increase RAS activation, melanoma cell growth, and migration. RASA2 expression was lost in more than 30% of human melanomas and was associated with reduced patient survival.

"As the RAS pathway is highly dysregulated in cancer, the discovery of an alternative mechanism for its activation is likely to stimulate an avalanche of further research in this field, and is highly likely to have direct clinical relevance. We are now going to focus on RASA2, to find out what proteins it communicates with in healthy cells and melanoma, as well as in the cells' response to targeted therapy," said senior author Dr. Yardena Samuels, professor of molecular cell biology at the Weizmann Institute of Science.

Related Links:

Weizmann Institute of Science


Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Liquid Based Cytology Production Machine
LBP-4032

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.